Cargando…

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma

BACKGROUND: Selective cyclooxygenase-2 (COX-2) inhibitors are analgesic, antipyretic, and anti-inflammatory drugs. They have been found to inhibit the development of glioma in laboratory investigations. Whether these drugs reduce the risk of glioma incidence in humans is unknown. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S., Bogdahn, Ulrich, Hau, Peter, Leitzmann, Michael F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752241/ https://www.ncbi.nlm.nih.gov/pubmed/26871579 http://dx.doi.org/10.1371/journal.pone.0149293

Ejemplares similares

Metabolic syndrome in relation to risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2016)

Diabetes, use of metformin, and the risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2017)

Antimicrobial drug use and the risk of glioma: A case–control study
por: Haedenkamp, Tareq M., et al.
Publicado: (2022)

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
por: Anssar, Tareq M., et al.
Publicado: (2019)

Drug Repurposing of Metabolic Agents in Malignant Glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms
por: Leidgens, Verena, et al.
Publicado: (2015)

No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study
por: Becker, Claudia, et al.
Publicado: (2015)

Use of statins or NSAIDs and survival of patients with high-grade glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro
por: Seliger, Corinna, et al.
Publicado: (2013)

Correction: Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro
por: Seliger, Corinna, et al.
Publicado: (2014)

Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro
por: Moeckel, Sylvia, et al.
Publicado: (2014)

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study
por: R. Charlier, Sarah H., et al.
Publicado: (2022)

Cancer risk in patients with chronic obstructive pulmonary disease
por: Schneider, Cornelia, et al.
Publicado: (2010)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016)

Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain
por: Theken, Katherine N., et al.
Publicado: (2019)

Cataract in patients with diabetes mellitus—incidence rates in the UK and risk factors
por: Becker, Claudia, et al.
Publicado: (2018)

Diabetes in Patients With Idiopathic Parkinson's Disease
por: Becker, Claudia, et al.
Publicado: (2008)

Lung toxicity of lomustine in the treatment of progressive gliomas
por: Seliger, Corinna, et al.
Publicado: (2022)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Cannabinoid system and cyclooxygenases inhibitors
por: Păunescu, H, et al.
Publicado: (2011)

Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
por: Tabrizchi, Reza
Publicado: (2006)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2006)

Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses
por: Whitfield-Cargile, Canaan M., et al.
Publicado: (2018)

Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
por: Gerthofer, Valeria, et al.
Publicado: (2018)

Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro
por: Moeckel, Sylvia, et al.
Publicado: (2016)

Comment on: Suissa and Azoulay. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Bodmer, Michael, et al.
Publicado: (2013)

Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas
por: Zhang, Fan, et al.
Publicado: (2017)

The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
por: Arslan, F, et al.
Publicado: (2007)

The effect of cyclooxygenase-2 selective inhibitors on the proliferation and apoptosis of human articular chondrocytes
por: Song, YW, et al.
Publicado: (2003)

Roles of Opioid Receptor Subtype in the Spinal Antinociception of Selective Cyclooxygenase 2 Inhibitor
por: Choi, Cheol Hun, et al.
Publicado: (2010)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor
por: Seo, Kyoung-Woo, et al.
Publicado: (2017)

Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_medo9u1cl6nfb3td2fe4daqi2i